CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-393125 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 16, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
30,000
Total Value
$1,264,809.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting&Technology Officer | Common Stock | โ | Sep 14, 2026 | Exercise/Conversion | 2,596 | $11.35 | $29,464.60 | 8,279 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Sep 14, 2026 | Exercise/Conversion | 7,404 | $13.56 | $100,398.24 | 15,683 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Sep 14, 2026 | Sale | 7,812 | $113.32 | $885,260.53 | 7,871 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Sep 14, 2026 | Sale | 2,188 | $114.12 | $249,686.46 | 5,683 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Stock option (right to buy) | Derivative | Sep 14, 2026 | Exercise/Conversion | 2,596 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Stock option (right to buy) | Derivative | Sep 14, 2026 | Exercise/Conversion | 7,404 | $0.00 | $0.00 | 4,167 | Direct | โ | View Details |